Replies to post #184302 on Biotech Values

[DewDiligence]

MDGN—Yes, these are real purchases, but I'm not certain they're bullish. That insiders purchased shares through the public offering could be construed as implying there wasn't sufficient demand from institutional investors to fill the offering.